The Enhanced Harm Reduction Working Group is a consortium of scientific experts, academics, policy makers, treatment providers and advocacy groups, working collaboratively to reduce the harms of intravenous drug use.

Aim

To develop the evidence base for reducing drug-related harm by piloting a Supervised Injection Facility (SIF) in the UK

Objectives

Rationale

We believe that there is good real-world evidence for the positive effects of Supervised Injection Facilities (SIFs) across the world.

SIFs are known by many names including Overdose Prevention Centres, and Drug Consumption Rooms. There are subtle nuances between each, however, their
function is to provide safe spaces for people to consume controlled drugs under the supervision of people who can save lives if overdoses occur.

Our aim is to develop the evidence base for reducing drug-related harms by piloting a SIF in the UK. This collaborative initiative will evaluate whether establishing a SIF would prove to be cost-effective, reduce crime, improve public health, reduce drug litter, and increase engagement in treatment services.

The EHRWG encourages the use of a participatory development approach in the design and development of a SIF. Consulting people who will be the end users of the SIF in the design, development and implementation is key to ensuring the model is fit for purpose, community-friendly, and holds the confidence of the local drug-using community. People who use drugs are sadly familiar with experiencing discrimination in health and social care settings. As such, those developing new services need to actively demonstrate their commitment to non-judgemental, rights-based approach and participatory development is a good starting point. When a community owns and supports the SIF, this ensures effective service user recruitment, quality management and advocacy.

Academic Experts

Prof Alex Stevens (Chair)

Professor of Criminal Justice

Prof David Nutt

Professor of Neuro-psychopharmacology

Prof Fiona Measham

Chair in Criminology

Prof Lindsay Forbes

Professor of Public Health

Prof Charlie Lloyd

Professor of Social Policy and Criminal Justice

Dr Euan Lawson

Editor of the British Journal of General Practice

Dr Gillian Shorter

Reader in Psychology

Dr Tim Williams

Consultant Addiction Psychiatrist

Dr Magdalena Harris

Associate Professor in the Sociology of Health

Roz Gittins

Drug Science Scientific Committee

Lucy Strang

Research Associate, Kings College London

Dr Andy Mcauley

Reader in Public Health,
Glasgow Caledonian University

Policy Specialists

Kirstie Douse

Head of Legal Services, Release

Mat Southwell

Associate Consultant, IDPC

Colleen Daniels

Deputy Director, Harm Reduction International

Jason Kew

Detective Chief Inspector, Thames Valley Police

Martin Powell

Head of Partnerships, Transform

Kirsten Horsburgh

Strategy Coordinator, Scottish Drugs Forum

Treatment Provider Representatives

Claire James

Deputy Director of Clinical Practice, Change Grow Live

Felicity Simpkin

Associate Director, With You

Martin Blakebrough

CEO, Kaleidoscope

Rob Barker

Campaigns and Communications Lead, Barod

Peter Krykant

Project Lead – Cranstoun

Lee Wilson

Regional Director, Humankind

Danny Ahmed

Clinical Partner, Foundations

Treatment Providers

The Enhanced Harm Reduction Working Group is supported by treatment providers to ensure that the stakeholders who would be delivering these services are consulted throughout.